Pseudallescheria boydii keratitis.
We describe a patient with Pseudallescheria boydii keratitis. The treatment of mycotic keratitis remains difficult. This case demonstrates that identification and susceptibility testing should be rapidly performed. In cases of indolent keratitis, the possibility of fungal infection should be kept in mind.
Ozkurt
Yelda
Y
1st Eye Clinic, Kartal Training and Research Hospital, Istanbul, Turkey.
Oral
Yesim
Y
Kulekci
Zeynep
Z
Benzonana
Nur
N
Ustaoglu
Reyhan
R
Dogan
Omer Kamil
OK
D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003519:Cyclopentolate / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007634:Keratitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008271:Mycetoma / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D010866:Natamycin / Q000627:therapeutic use; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D011541:Pseudallescheria / Q000302:isolation & purification*
D000935:Antifungal Agents; D005938:Glucocorticoids; D000666:Amphotericin B; C009935:prednisolone acetate; D010866:Natamycin; D011239:Prednisolone; D003519:Cyclopentolate